Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China.

ABSTRACT:

Objectives

To investigate the prevalence, awareness, treatment and control of dyslipidaemia and its associated factors in eastern China.

Design

Cross-sectional study.

Setting

Data were collected from the 2017 Nanjing Chronic Disease and Risk Factor Surveillance.

Participants

This study included 60 283 participants aged ≥18 years.

Outcome measures

Prevalence of dyslipidaemia was defined as self-reported history of dyslipidaemia and/or the use of lipid-lowering medication, and/or meeting at least one of the following during on-site investigation: total cholesterol ≥6.2 mmol/L, triglyceride ≥2.3 mmol/L, low-density lipoprotein cholesterol ≥4.1 mmol/L and high-density lipoprotein cholesterol <1.0 mmol/L. Dyslipidaemia awareness was defined as the proportion

SUBMITTER: Chen Y 

PROVIDER: S-EPMC10748968 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature